The Market Reports

Index

1 Naloxone Market Overview
1.1 Product Overview and Scope of Naloxone
1.2 Naloxone Segment by Type
1.2.1 Global Naloxone Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Spray Forms
1.2.3 Injectable Forms
1.3 Naloxone Segment by Application
1.3.1 Global Naloxone Sales Comparison by Application: (2021-2027)
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Global Naloxone Market Size Estimates and Forecasts
1.4.1 Global Naloxone Revenue 2016-2027
1.4.2 Global Naloxone Sales 2016-2027
1.4.3 Naloxone Market Size by Region: 2016 Versus 2021 Versus 2027

2 Naloxone Market Competition by Manufacturers
2.1 Global Naloxone Sales Market Share by Manufacturers (2016-2021)
2.2 Global Naloxone Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Naloxone Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Naloxone Manufacturing Sites, Area Served, Product Type
2.5 Naloxone Market Competitive Situation and Trends
2.5.1 Naloxone Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Naloxone Players Market Share by Revenue
2.5.3 Global Naloxone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Naloxone Retrospective Market Scenario by Region
3.1 Global Naloxone Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Naloxone Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Naloxone Market Facts & Figures by Country
3.3.1 North America Naloxone Sales by Country
3.3.2 North America Naloxone Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Naloxone Market Facts & Figures by Country
3.4.1 Europe Naloxone Sales by Country
3.4.2 Europe Naloxone Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Naloxone Market Facts & Figures by Region
3.5.1 Asia Pacific Naloxone Sales by Region
3.5.2 Asia Pacific Naloxone Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Naloxone Market Facts & Figures by Country
3.6.1 Latin America Naloxone Sales by Country
3.6.2 Latin America Naloxone Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Naloxone Market Facts & Figures by Country
3.7.1 Middle East and Africa Naloxone Sales by Country
3.7.2 Middle East and Africa Naloxone Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Naloxone Historic Market Analysis by Type
4.1 Global Naloxone Sales Market Share by Type (2016-2021)
4.2 Global Naloxone Revenue Market Share by Type (2016-2021)
4.3 Global Naloxone Price by Type (2016-2021)

5 Global Naloxone Historic Market Analysis by Application
5.1 Global Naloxone Sales Market Share by Application (2016-2021)
5.2 Global Naloxone Revenue Market Share by Application (2016-2021)
5.3 Global Naloxone Price by Application (2016-2021)

6 Key Companies Profiled
6.1 ADAPT Pharma
6.1.1 ADAPT Pharma Corporation Information
6.1.2 ADAPT Pharma Description and Business Overview
6.1.3 ADAPT Pharma Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ADAPT Pharma Naloxone Product Portfolio
6.1.5 ADAPT Pharma Recent Developments/Updates
6.2 Amphastar Pharmaceuticals
6.2.1 Amphastar Pharmaceuticals Corporation Information
6.2.2 Amphastar Pharmaceuticals Description and Business Overview
6.2.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
6.2.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Naloxone Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Kaleo
6.4.1 Kaleo Corporation Information
6.4.2 Kaleo Description and Business Overview
6.4.3 Kaleo Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Kaleo Naloxone Product Portfolio
6.4.5 Kaleo Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sandoz Naloxone Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Amneal Pharmaceuticals
6.6.1 Amneal Pharmaceuticals Corporation Information
6.6.2 Amneal Pharmaceuticals Description and Business Overview
6.6.3 Amneal Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Amneal Pharmaceuticals Naloxone Product Portfolio
6.6.5 Amneal Pharmaceuticals Recent Developments/Updates
6.7 West Ward Pharmaceuticals
6.6.1 West Ward Pharmaceuticals Corporation Information
6.6.2 West Ward Pharmaceuticals Description and Business Overview
6.6.3 West Ward Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 West Ward Pharmaceuticals Naloxone Product Portfolio
6.7.5 West Ward Pharmaceuticals Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Naloxone Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Naloxone Product Portfolio
6.8.5 Mylan Recent Developments/Updates

7 Naloxone Manufacturing Cost Analysis
7.1 Naloxone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Naloxone
7.4 Naloxone Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Naloxone Distributors List
8.3 Naloxone Customers

9 Naloxone Market Dynamics
9.1 Naloxone Industry Trends
9.2 Naloxone Growth Drivers
9.3 Naloxone Market Challenges
9.4 Naloxone Market Restraints

10 Global Market Forecast
10.1 Naloxone Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Naloxone by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Naloxone by Type (2022-2027)
10.2 Naloxone Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Naloxone by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Naloxone by Application (2022-2027)
10.3 Naloxone Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Naloxone by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Naloxone by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Naloxone Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Naloxone Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Naloxone Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Naloxone Covered in This Study
Table 5. Global Naloxone Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Naloxone Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Naloxone Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Naloxone Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Naloxone Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Naloxone Manufacturing Sites and Area Served
Table 11. Manufacturers Naloxone Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Naloxone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Naloxone as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Naloxone Sales by Region (2016-2021) & (K Units)
Table 16. Global Naloxone Sales Market Share by Region (2016-2021)
Table 17. Global Naloxone Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Naloxone Sales by Country (2016-2021) & (K Units)
Table 19. North America Naloxone Sales Market Share by Country (2016-2021)
Table 20. North America Naloxone Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Naloxone Revenue Market Share by Country (2016-2021)
Table 22. Europe Naloxone Sales by Country (2016-2021) & (K Units)
Table 23. Europe Naloxone Sales Market Share by Country (2016-2021)
Table 24. Europe Naloxone Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Naloxone Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Naloxone Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Naloxone Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Naloxone Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Naloxone Revenue Market Share by Region (2016-2021)
Table 30. Latin America Naloxone Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Naloxone Sales Market Share by Country (2016-2021)
Table 32. Latin America Naloxone Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Naloxone Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Naloxone Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Naloxone Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Naloxone Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Naloxone Revenue Market Share by Country (2016-2021)
Table 38. Global Naloxone Sales (K Units) by Type (2016-2021)
Table 39. Global Naloxone Sales Market Share by Type (2016-2021)
Table 40. Global Naloxone Revenue (Million US$) by Type (2016-2021)
Table 41. Global Naloxone Revenue Share by Type (2016-2021)
Table 42. Global Naloxone Price (USD/Unit) by Type (2016-2021)
Table 43. Global Naloxone Sales (K Units) by Application (2016-2021)
Table 44. Global Naloxone Sales Market Share by Application (2016-2021)
Table 45. Global Naloxone Revenue (Million US$) by Application (2016-2021)
Table 46. Global Naloxone Revenue Share by Application (2016-2021)
Table 47. Global Naloxone Price (USD/Unit) by Application (2016-2021)
Table 48. ADAPT Pharma Corporation Information
Table 49. ADAPT Pharma Description and Business Overview
Table 50. ADAPT Pharma Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. ADAPT Pharma Naloxone Product
Table 52. ADAPT Pharma Recent Developments/Updates
Table 53. Amphastar Pharmaceuticals Corporation Information
Table 54. Amphastar Pharmaceuticals Description and Business Overview
Table 55. Amphastar Pharmaceuticals Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Amphastar Pharmaceuticals Naloxone Product
Table 57. Amphastar Pharmaceuticals Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Naloxone Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Kaleo Corporation Information
Table 64. Kaleo Description and Business Overview
Table 65. Kaleo Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Kaleo Naloxone Product
Table 67. Kaleo Recent Developments/Updates
Table 68. Sandoz Corporation Information
Table 69. Sandoz Description and Business Overview
Table 70. Sandoz Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Sandoz Naloxone Product
Table 72. Sandoz Recent Developments/Updates
Table 73. Amneal Pharmaceuticals Corporation Information
Table 74. Amneal Pharmaceuticals Description and Business Overview
Table 75. Amneal Pharmaceuticals Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Amneal Pharmaceuticals Naloxone Product
Table 77. Amneal Pharmaceuticals Recent Developments/Updates
Table 78. West Ward Pharmaceuticals Corporation Information
Table 79. West Ward Pharmaceuticals Description and Business Overview
Table 80. West Ward Pharmaceuticals Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. West Ward Pharmaceuticals Naloxone Product
Table 82. West Ward Pharmaceuticals Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Naloxone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Mylan Naloxone Product
Table 87. Mylan Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Naloxone Distributors List
Table 91. Naloxone Customers List
Table 92. Naloxone Market Trends
Table 93. Naloxone Growth Drivers
Table 94. Naloxone Market Challenges
Table 95. Naloxone Market Restraints
Table 96. Global Naloxone Sales Forecast by Type (2022-2027) & (K Units)
Table 97. Global Naloxone Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Naloxone Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Naloxone Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Naloxone Sales Forecast by Application (2022-2027) & (K Units)
Table 101. Global Naloxone Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Naloxone Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Naloxone Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Naloxone Sales Forecast by Region (2022-2027) & (K Units)
Table 105. Global Naloxone Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Naloxone Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Naloxone Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Naloxone
Figure 2. Global Naloxone Market Share by Type in 2020 & 2027
Figure 3. Spray Forms Product Picture
Figure 4. Injectable Forms Product Picture
Figure 5. Global Naloxone Market Share by Application in 2020 & 2027
Figure 6. Drug Store
Figure 7. Hospital Pharmacies
Figure 8. Online
Figure 9. Global Naloxone Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Naloxone Market Size 2016-2027 (US$ Million)
Figure 11. Global Naloxone Sales 2016-2027 (K Units)
Figure 12. Global Naloxone Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Naloxone Sales Share by Manufacturers in 2020
Figure 14. Global Naloxone Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Naloxone Players: Market Share by Revenue in 2020
Figure 16. Naloxone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Naloxone Sales Market Share by Region (2016-2021)
Figure 18. Global Naloxone Sales Market Share by Region in 2020
Figure 19. Global Naloxone Revenue Market Share by Region (2016-2021)
Figure 20. Global Naloxone Revenue Market Share by Region in 2020
Figure 21. U.S. Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Naloxone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Naloxone by Type (2016-2021)
Figure 46. Sales Market Share of Naloxone by Application (2016-2021)
Figure 47. Sales Market Share of Naloxone by Application in 2020
Figure 48. Revenue Share of Naloxone by Application (2016-2021)
Figure 49. Revenue Share of Naloxone by Application in 2020
Figure 50. Manufacturing Cost Structure of Naloxone
Figure 51. Manufacturing Process Analysis of Naloxone
Figure 52. Naloxone Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed